Read More 1 minute read Hiring News News Judo Bio Secures $100M Financing to Advance Kidney-Targeted Oligonucleotide Medicines Key Highlights Judo Bio secures $100M in initial financing for kidney-targeted medicines. Series A co-led by Atlas Venture, TCG, and… byChris-Anne RoqueOctober 10, 2024